Clinical Trial

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-09-03; most recent amendment 2025-05-08.
Status change: Recruiting → Active, Not Recruiting 2025-05-08
Status change: Active, Not Recruiting → Recruiting 2023-04-10
Status change: Recruiting → Active, Not Recruiting 2022-12-12
Trial Details
NCT Number NCT04540900
Lead Sponsor Krystal Biotech, Inc.
Conditions Skin Roughness, Wrinkle, Fine Lines, Skin Thickness
Enrollment 85 participants
Start Date 2020-10-07
Primary Completion 2024-10-16 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-13